NIH-funded research R21 grant

Investigating how blood pressure control affects heart failure risk in adults with type 2 diabetes.

Official title: Cardiac biomarkers, intensive blood pressure treatment and risk of adverse cardiovascular outcomes in type 2 diabetes, a secondary analysis of the ACCORD BP

Funded at Ut Southwestern Medical Center · NIH-10901969 · Data updated 2026-11-12

This study is looking at how keeping blood pressure in check can help prevent heart failure in adults with type 2 diabetes, and it will check blood samples to find out if certain markers can help identify those who might need extra help with their blood pressure management.

More Diabetes research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startAugust 15, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$124,885
NIH project number5R21HL169708-02
Project IDNIH-10901969 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who have been diagnosed with type 2 diabetes and are at risk for heart failure.

Less likely to help

Patients who do not have type 2 diabetes or those who are not at risk for heart failure may not benefit from this research.

What this research studies

This research focuses on understanding the relationship between blood pressure control and the risk of heart failure in adults with type 2 diabetes. It aims to identify high-risk individuals who may benefit more from intensive blood pressure management by measuring specific cardiac biomarkers. Participants from the ACCORD-BP trial will have their blood samples analyzed for these biomarkers at various points in time. The goal is to determine if these biomarkers can guide treatment decisions to better prevent heart failure.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing heart failure in adults with type 2 diabetes.

How similar studies have gone: Previous research has shown that cardiac biomarkers can be useful in predicting heart failure risk, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Pandey, Ambarish — Ut Southwestern Medical Center
  • Study coordinator: Pandey, Ambarish

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.